Clinical Trials Directory

Trials / Completed

CompletedNCT06484452

SpO2 Validation Study - Philips FAST 2024

Status
Completed
Phase
Study type
Observational
Enrollment
113 (actual)
Sponsor
Philips Clinical & Medical Affairs Global · Industry
Sex
All
Age
18 Years – 50 Years
Healthy volunteers
Accepted

Summary

Validation study to compare the accuracy of non-invasive Philips SpO2 sensors in detecting blood oxygen levels compared to invasive methods requiring a blood draw and lab analysis.

Detailed description

To validate the SpO2 accuracy of the SpO2 sensors under test with the Philips FAST Pulse Oximetry technology during non-motion conditions over the range of 70-100% SaO2, when compared with the reference SaO2 obtained from CO-Oximetry analysis of arterial blood samples.

Conditions

Interventions

TypeNameDescription
DEVICENo InterventionNo Intervention

Timeline

Start date
2024-05-06
Primary completion
2024-08-29
Completion
2024-08-29
First posted
2024-07-03
Last updated
2025-09-16

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT06484452. Inclusion in this directory is not an endorsement.

SpO2 Validation Study - Philips FAST 2024 (NCT06484452) · Clinical Trials Directory